Clinical Trials Study
Prediction of the effect on antihyperglycaemic action of sitagliptin by plasma active form glucagon-like peptide-1

World J Diabetes
7(11):230-238.
Published online Jun 10, 2016.
doi: 10.4239/wjd.v7.i11.230
Abstract (1551)
|
Core Tip (1390)
|
Full Article (HTML) (4279)
|
Figures (1-3) (398)
|
Tables (1-2) (841)
|
Full Article (PDF)-1110K (806)
|
Audio-2311K (22)
|
Peer-Review Report-107K (295)
|
Answering Reviewers-180K (277)
|
Received: 01/21/2016
|
Revised: 03/12/2016
|
Accepted: 04/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (19406)
|
Similar Articles (0)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letters To The Editor
World J Diabetes
7(11):239-242.
Published online Jun 10, 2016.
doi: 10.4239/wjd.v7.i11.239
Abstract (1354)
|
Core Tip (1270)
|
Full Article (HTML) (3468)
|
Full Article (PDF)-719K (740)
|
Audio-822K (16)
|
Peer-Review Report-120K (253)
|
Answering Reviewers-8K (177)
|
Received: 01/31/2016
|
Revised: 03/06/2016
|
Accepted: 03/25/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (11722)
|
Similar Articles (0)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open